NASDAQ:ESTA

Establishment Labs (ESTA) Stock Price, News & Analysis

$49.69
+1.42 (+2.94%)
(As of 04/23/2024 ET)
Today's Range
$47.92
$50.03
50-Day Range
$35.80
$55.38
52-Week Range
$16.96
$75.24
Volume
266,011 shs
Average Volume
430,708 shs
Market Capitalization
$1.36 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$55.00

Establishment Labs MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
10.7% Upside
$55.00 Price Target
Short Interest
Bearish
21.72% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.65mentions of Establishment Labs in the last 14 days
Based on 8 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.58) to ($0.48) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.78 out of 5 stars

Medical Sector

821st out of 909 stocks

Surgical Appliances & Supplies Industry

17th out of 17 stocks

ESTA stock logo

About Establishment Labs Stock (NASDAQ:ESTA)

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

ESTA Stock Price History

ESTA Stock News Headlines

Establishment Labs (NASDAQ:ESTA) Shares Down 5.3%
The only defense company you should be looking at
This is the ONLY defense company you should be watching right now.
The only defense company you should be looking at
This is the ONLY defense company you should be watching right now.
Key Takeaways From Establishment Labs Hldgs Analyst Ratings
See More Headlines
Receive ESTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Establishment Labs and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2024
Today
4/23/2024
Next Earnings (Estimated)
5/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
N/A
Current Symbol
NASDAQ:ESTA
Fax
N/A
Employees
908
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$55.00
High Stock Price Target
$65.00
Low Stock Price Target
$47.00
Potential Upside/Downside
+10.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$-78,500,000.00
Pretax Margin
-47.58%

Debt

Sales & Book Value

Annual Sales
$165.15 million
Book Value
$0.71 per share

Miscellaneous

Free Float
24,319,000
Market Cap
$1.36 billion
Optionable
Optionable
Beta
1.24
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Juan Jose Chacon QuirosMr. Juan Jose Chacon Quiros (Age 52)
    Founder, CEO & Executive Director
    Comp: $913.37k
  • Mr. Rajbir Singh Denhoy (Age 54)
    Chief Financial Officer
    Comp: $570.29k
  • Mr. S. Ross Mansbach (Age 57)
    General Counsel & Chief Compliance Officer
    Comp: $379.53k
  • Mr. Roberto de Mezerville (Age 43)
    Chief Technology Officer
  • Mr. Salvador Santos Dada (Age 42)
    Head of Special Projects
    Comp: $468.62k
  • Ms. Rosalyn Cole d'Incelli
    SVP of Global Clinical, Medical & US Regulatory Affairs
  • Ms. Elizabeth Panzica Newman
    VP & Head of U.S Business Unit
  • Mr. Ivan Bilic
    Senior Vice President of Commercial Operations - OUS
  • Ms. Neeta Toprani
    Corporate Secretary

ESTA Stock Analysis - Frequently Asked Questions

Should I buy or sell Establishment Labs stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Establishment Labs in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ESTA shares.
View ESTA analyst ratings
or view top-rated stocks.

What is Establishment Labs' stock price target for 2024?

5 brokers have issued 12-month price targets for Establishment Labs' stock. Their ESTA share price targets range from $47.00 to $65.00. On average, they anticipate the company's stock price to reach $55.00 in the next year. This suggests a possible upside of 10.7% from the stock's current price.
View analysts price targets for ESTA
or view top-rated stocks among Wall Street analysts.

How have ESTA shares performed in 2024?

Establishment Labs' stock was trading at $25.89 at the beginning of 2024. Since then, ESTA shares have increased by 91.9% and is now trading at $49.69.
View the best growth stocks for 2024 here
.

Are investors shorting Establishment Labs?

Establishment Labs saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 4,930,000 shares, an increase of 8.1% from the March 15th total of 4,560,000 shares. Based on an average daily trading volume, of 457,400 shares, the days-to-cover ratio is currently 10.8 days. Currently, 21.7% of the company's shares are short sold.
View Establishment Labs' Short Interest
.

When is Establishment Labs' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024.
View our ESTA earnings forecast
.

How were Establishment Labs' earnings last quarter?

Establishment Labs Holdings Inc. (NASDAQ:ESTA) announced its earnings results on Wednesday, February, 28th. The company reported ($0.79) earnings per share for the quarter, topping the consensus estimate of ($0.95) by $0.16. The business earned $31.60 million during the quarter, compared to analyst estimates of $31.44 million. Establishment Labs had a negative net margin of 47.53% and a negative trailing twelve-month return on equity of 357.81%. The company's revenue for the quarter was down 27.9% compared to the same quarter last year. During the same quarter last year, the company posted ($0.55) EPS.

What ETFs hold Establishment Labs' stock?

ETFs with the largest weight of Establishment Labs (NASDAQ:ESTA) stock in their portfolio include Simplify Health Care ETF (PINK).First Trust Nasdaq Lux Digital Health Solutions ETF (EKG).

What guidance has Establishment Labs issued on next quarter's earnings?

Establishment Labs updated its FY 2024 earnings guidance on Wednesday, February, 28th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $174.0 million-$184.0 million, compared to the consensus revenue estimate of $173.7 million.

What other stocks do shareholders of Establishment Labs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Establishment Labs investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Sientra (SIEN), Allergan (AGN), BCE (BCE), Canadian Imperial Bank of Commerce (CM), Canadian Natural Resources (CNQ), Chevron (CVX) and Evolus (EOLS).

When did Establishment Labs IPO?

Establishment Labs (ESTA) raised $50 million in an initial public offering (IPO) on Thursday, July 19th 2018. The company issued 3,100,000 shares at $15.00-$17.00 per share. Jefferies and Cowen served as the underwriters for the IPO and BTIG was co-manager.

Who are Establishment Labs' major shareholders?

Establishment Labs' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Rice Hall James & Associates LLC (2.69%) and Stableford Capital II LLC (0.11%). Insiders that own company stock include Dennis E Condon, Dennis E Condon, Edward J Schutter, Jw Asset Management, Llc, Leslie Gillin, Lisa Gersh, Mezerville Roberto De, Nicholas Sheridan Lewin, Raj Denhoy and Renee Gaeta.
View institutional ownership trends
.

How do I buy shares of Establishment Labs?

Shares of ESTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ESTA) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners